At its August 15, 2017 meeting, the Board approved more than $115 million to fund 20 comparative clinical effectiveness research (CER) studies on a range of conditions that impose high burdens on patients, their families and the healthcare system, and an additional $4 million to support four projects focused on improving methods for conducting CER. Read more about these projects.
Among the 20 CER studies, the Board approved nearly $74 million to fund seven projects that compare the effectiveness of different strategies for delivering palliative care, and just under $10 million to fund two projects that compare the effectiveness of strategies designed to reduce unsafe opioid prescribing by improving pain management.
In addition, the Board approved the appointment of 26 individuals as new members on PCORI’s seven multi-stakeholder advisory panels. The new panelists bring a range of perspectives to their work with PCORI. They include researchers, patients, patient advocates, caregivers and clinicians, as well as representatives of health insurers, health systems and academic institutions. The Board also approved the reappointment of seven existing advisory panelists.
All PCORI Board meetings are open to the public. This meeting was held via teleconference/webinar with no public comment period.